Large posttraumatic stress disorder improvement and antidepressant medication adherence

Joanne Salas, Jeffrey F. Scherrer, Peter Tuerk, Carissa van den Berk-Clark, Kathleen M. Chard, F. David Schneider, Paula P. Schnurr, Matthew J. Friedman, Sonya B. Norman, Beth E. Cohen, Patrick Lustman

Research output: Contribution to journalArticle

Abstract

Background: Patients with vs. without posttraumatic stress disorder (PTSD) are more likely to have poor antidepressant medication (ADM) adherence but it is unclear if improved PTSD is associated with ADM adherence. We determined if clinically meaningful PTSD symptom reduction was associated with ADM adherence. Methods: Electronic health record data (2008–2015) was obtained from 742 Veterans Health Affairs (VHA) patients using PTSD specialty clinics with a PTSD diagnosis and PTSD checklist (PCL) score ≥50. The last PCL in the exposure year after the first PCL≥50 was used to identify patients with a clinically meaningful PCL decrease (≥20 point) versus those without (< 20 point). Patients had a depression diagnosis in the 12-months before the exposure year and received an ADM in the exposure year. Proportion of days covered ≥80% in exposure year defined adherence. Confounding was controlled using propensity scores and inverse probability of treatment weighting. Results: Patients were 42.2 ± 13.1 years of age, 63.9% white and 18.9% had a clinically meaningful PCL decrease. After controlling for confounding variables, patients with vs. without a clinically meaningful PCL decrease were significantly more likely to be adherent (OR = 1.78; 95% CI:1.16–2.73). However, adherence remained low in both patients with and without meaningful PCL decrease (53.5% vs. 39.3%). Limitations: The sample was limited to VHA patients. Patients may not have taken medication as prescribed. Conclusions: Large reductions in PTSD symptoms are associated with ADM adherence. Prior literature suggests ADM adherence improves depression symptoms. Thus, PTSD symptom reduction may lead to better depression outcomes.

Original languageEnglish (US)
Pages (from-to)119-123
Number of pages5
JournalJournal of affective disorders
Volume260
DOIs
StatePublished - Jan 1 2020

Fingerprint

Medication Adherence
Post-Traumatic Stress Disorders
Antidepressive Agents
Checklist
Veterans Health
Depression
Propensity Score
Confounding Factors (Epidemiology)
Electronic Health Records

Keywords

  • Antidepressant medication adherence
  • Depression
  • PTSD symptoms

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Salas, J., Scherrer, J. F., Tuerk, P., van den Berk-Clark, C., Chard, K. M., Schneider, F. D., ... Lustman, P. (2020). Large posttraumatic stress disorder improvement and antidepressant medication adherence. Journal of affective disorders, 260, 119-123. https://doi.org/10.1016/j.jad.2019.08.095

Large posttraumatic stress disorder improvement and antidepressant medication adherence. / Salas, Joanne; Scherrer, Jeffrey F.; Tuerk, Peter; van den Berk-Clark, Carissa; Chard, Kathleen M.; Schneider, F. David; Schnurr, Paula P.; Friedman, Matthew J.; Norman, Sonya B.; Cohen, Beth E.; Lustman, Patrick.

In: Journal of affective disorders, Vol. 260, 01.01.2020, p. 119-123.

Research output: Contribution to journalArticle

Salas, J, Scherrer, JF, Tuerk, P, van den Berk-Clark, C, Chard, KM, Schneider, FD, Schnurr, PP, Friedman, MJ, Norman, SB, Cohen, BE & Lustman, P 2020, 'Large posttraumatic stress disorder improvement and antidepressant medication adherence', Journal of affective disorders, vol. 260, pp. 119-123. https://doi.org/10.1016/j.jad.2019.08.095
Salas, Joanne ; Scherrer, Jeffrey F. ; Tuerk, Peter ; van den Berk-Clark, Carissa ; Chard, Kathleen M. ; Schneider, F. David ; Schnurr, Paula P. ; Friedman, Matthew J. ; Norman, Sonya B. ; Cohen, Beth E. ; Lustman, Patrick. / Large posttraumatic stress disorder improvement and antidepressant medication adherence. In: Journal of affective disorders. 2020 ; Vol. 260. pp. 119-123.
@article{11600a1d05b24e49b2e29430bc7d4b36,
title = "Large posttraumatic stress disorder improvement and antidepressant medication adherence",
abstract = "Background: Patients with vs. without posttraumatic stress disorder (PTSD) are more likely to have poor antidepressant medication (ADM) adherence but it is unclear if improved PTSD is associated with ADM adherence. We determined if clinically meaningful PTSD symptom reduction was associated with ADM adherence. Methods: Electronic health record data (2008–2015) was obtained from 742 Veterans Health Affairs (VHA) patients using PTSD specialty clinics with a PTSD diagnosis and PTSD checklist (PCL) score ≥50. The last PCL in the exposure year after the first PCL≥50 was used to identify patients with a clinically meaningful PCL decrease (≥20 point) versus those without (< 20 point). Patients had a depression diagnosis in the 12-months before the exposure year and received an ADM in the exposure year. Proportion of days covered ≥80{\%} in exposure year defined adherence. Confounding was controlled using propensity scores and inverse probability of treatment weighting. Results: Patients were 42.2 ± 13.1 years of age, 63.9{\%} white and 18.9{\%} had a clinically meaningful PCL decrease. After controlling for confounding variables, patients with vs. without a clinically meaningful PCL decrease were significantly more likely to be adherent (OR = 1.78; 95{\%} CI:1.16–2.73). However, adherence remained low in both patients with and without meaningful PCL decrease (53.5{\%} vs. 39.3{\%}). Limitations: The sample was limited to VHA patients. Patients may not have taken medication as prescribed. Conclusions: Large reductions in PTSD symptoms are associated with ADM adherence. Prior literature suggests ADM adherence improves depression symptoms. Thus, PTSD symptom reduction may lead to better depression outcomes.",
keywords = "Antidepressant medication adherence, Depression, PTSD symptoms",
author = "Joanne Salas and Scherrer, {Jeffrey F.} and Peter Tuerk and {van den Berk-Clark}, Carissa and Chard, {Kathleen M.} and Schneider, {F. David} and Schnurr, {Paula P.} and Friedman, {Matthew J.} and Norman, {Sonya B.} and Cohen, {Beth E.} and Patrick Lustman",
year = "2020",
month = "1",
day = "1",
doi = "10.1016/j.jad.2019.08.095",
language = "English (US)",
volume = "260",
pages = "119--123",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - Large posttraumatic stress disorder improvement and antidepressant medication adherence

AU - Salas, Joanne

AU - Scherrer, Jeffrey F.

AU - Tuerk, Peter

AU - van den Berk-Clark, Carissa

AU - Chard, Kathleen M.

AU - Schneider, F. David

AU - Schnurr, Paula P.

AU - Friedman, Matthew J.

AU - Norman, Sonya B.

AU - Cohen, Beth E.

AU - Lustman, Patrick

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Background: Patients with vs. without posttraumatic stress disorder (PTSD) are more likely to have poor antidepressant medication (ADM) adherence but it is unclear if improved PTSD is associated with ADM adherence. We determined if clinically meaningful PTSD symptom reduction was associated with ADM adherence. Methods: Electronic health record data (2008–2015) was obtained from 742 Veterans Health Affairs (VHA) patients using PTSD specialty clinics with a PTSD diagnosis and PTSD checklist (PCL) score ≥50. The last PCL in the exposure year after the first PCL≥50 was used to identify patients with a clinically meaningful PCL decrease (≥20 point) versus those without (< 20 point). Patients had a depression diagnosis in the 12-months before the exposure year and received an ADM in the exposure year. Proportion of days covered ≥80% in exposure year defined adherence. Confounding was controlled using propensity scores and inverse probability of treatment weighting. Results: Patients were 42.2 ± 13.1 years of age, 63.9% white and 18.9% had a clinically meaningful PCL decrease. After controlling for confounding variables, patients with vs. without a clinically meaningful PCL decrease were significantly more likely to be adherent (OR = 1.78; 95% CI:1.16–2.73). However, adherence remained low in both patients with and without meaningful PCL decrease (53.5% vs. 39.3%). Limitations: The sample was limited to VHA patients. Patients may not have taken medication as prescribed. Conclusions: Large reductions in PTSD symptoms are associated with ADM adherence. Prior literature suggests ADM adherence improves depression symptoms. Thus, PTSD symptom reduction may lead to better depression outcomes.

AB - Background: Patients with vs. without posttraumatic stress disorder (PTSD) are more likely to have poor antidepressant medication (ADM) adherence but it is unclear if improved PTSD is associated with ADM adherence. We determined if clinically meaningful PTSD symptom reduction was associated with ADM adherence. Methods: Electronic health record data (2008–2015) was obtained from 742 Veterans Health Affairs (VHA) patients using PTSD specialty clinics with a PTSD diagnosis and PTSD checklist (PCL) score ≥50. The last PCL in the exposure year after the first PCL≥50 was used to identify patients with a clinically meaningful PCL decrease (≥20 point) versus those without (< 20 point). Patients had a depression diagnosis in the 12-months before the exposure year and received an ADM in the exposure year. Proportion of days covered ≥80% in exposure year defined adherence. Confounding was controlled using propensity scores and inverse probability of treatment weighting. Results: Patients were 42.2 ± 13.1 years of age, 63.9% white and 18.9% had a clinically meaningful PCL decrease. After controlling for confounding variables, patients with vs. without a clinically meaningful PCL decrease were significantly more likely to be adherent (OR = 1.78; 95% CI:1.16–2.73). However, adherence remained low in both patients with and without meaningful PCL decrease (53.5% vs. 39.3%). Limitations: The sample was limited to VHA patients. Patients may not have taken medication as prescribed. Conclusions: Large reductions in PTSD symptoms are associated with ADM adherence. Prior literature suggests ADM adherence improves depression symptoms. Thus, PTSD symptom reduction may lead to better depression outcomes.

KW - Antidepressant medication adherence

KW - Depression

KW - PTSD symptoms

UR - http://www.scopus.com/inward/record.url?scp=85071723656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071723656&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2019.08.095

DO - 10.1016/j.jad.2019.08.095

M3 - Article

C2 - 31494363

AN - SCOPUS:85071723656

VL - 260

SP - 119

EP - 123

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -